Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Robert L Fine

Showing results (21-30 of 65) with videos related to

Pageof 7
Sort By:
Advanced Drug Delivery Reviews|February 22, 2005
The role of alpha-helical structure in p53 peptides as a determinant for their mechanism of cell death: necrosis versus apoptosisRamon Rosal, Paul Brandt-Rauf, Matthew R Pincus, et al.
Head & Neck|April 11, 2009
Head and neck squamous cell carcinoma in FAMMM syndromeVladimir Vinarsky, Robert L Fine, Adel Assaad, et al.
Pituitary|December 5, 2009
Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumorMarie S Thearle, Pamela U Freda, Jeffrey N Bruce, et al.
Cancer Research|April 3, 2003
Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143Yin Li, Anthony J Raffo, Lisa Drew, et al.
Journal of Neuro-Oncology|October 4, 2011
The feasibility of real-time in vivo optical detection of blood-brain barrier disruption with indocyanine greenAysegul Ergin, Mei Wang, Jane Y Zhang, et al.
Neurosurgery|March 25, 2011
Intra-arterial mitoxantrone delivery in rabbits: an optical pharmacokinetic studyShailendra Joshi, Roberto Reif, Mei Wang, et al.
Cancer|September 9, 2010
First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomasJonathan R Strosberg, Robert L Fine, Junsung Choi, et al.
Current Treatment Options in Gastroenterology|September 4, 2004
Advances in the Genetic Screening, Work-up, and Treatment of Pancreatic CancerHarold Frucht, Peter D. Stevens, David R. Fogelman, et al.
The Journal of Clinical Ethics|August 9, 2013
The intensity and frequency of moral distress among different healthcare disciplinesSusan Houston, Mark A Casanova, Marygrace Leveille, et al.
International Journal of Cancer|January 13, 2005
Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cellsYin Li, Yuehua Mao, Ramon V Rosal, et al.
Pageof 7

Showing results (21-30 of 65) with videos related to

Sort By:
Pageof 7
Advanced Drug Delivery Reviews|February 22, 2005
The role of alpha-helical structure in p53 peptides as a determinant for their mechanism of cell death: necrosis versus apoptosisRamon Rosal, Paul Brandt-Rauf, Matthew R Pincus, et al.
Head & Neck|April 11, 2009
Head and neck squamous cell carcinoma in FAMMM syndromeVladimir Vinarsky, Robert L Fine, Adel Assaad, et al.
Pituitary|December 5, 2009
Temozolomide (Temodar®) and capecitabine (Xeloda®) treatment of an aggressive corticotroph pituitary tumorMarie S Thearle, Pamela U Freda, Jeffrey N Bruce, et al.
Cancer Research|April 3, 2003
Fas-mediated apoptosis is dependent on wild-type p53 status in human cancer cells expressing a temperature-sensitive p53 mutant alanine-143Yin Li, Anthony J Raffo, Lisa Drew, et al.
Journal of Neuro-Oncology|October 4, 2011
The feasibility of real-time in vivo optical detection of blood-brain barrier disruption with indocyanine greenAysegul Ergin, Mei Wang, Jane Y Zhang, et al.
Neurosurgery|March 25, 2011
Intra-arterial mitoxantrone delivery in rabbits: an optical pharmacokinetic studyShailendra Joshi, Roberto Reif, Mei Wang, et al.
Cancer|September 9, 2010
First-line chemotherapy with capecitabine and temozolomide in patients with metastatic pancreatic endocrine carcinomasJonathan R Strosberg, Robert L Fine, Junsung Choi, et al.
Current Treatment Options in Gastroenterology|September 4, 2004
Advances in the Genetic Screening, Work-up, and Treatment of Pancreatic CancerHarold Frucht, Peter D. Stevens, David R. Fogelman, et al.
The Journal of Clinical Ethics|August 9, 2013
The intensity and frequency of moral distress among different healthcare disciplinesSusan Houston, Mark A Casanova, Marygrace Leveille, et al.
International Journal of Cancer|January 13, 2005
Selective induction of apoptosis through the FADD/caspase-8 pathway by a p53 c-terminal peptide in human pre-malignant and malignant cellsYin Li, Yuehua Mao, Ramon V Rosal, et al.
Pageof 7